Uveitis Treatment Market by Drug Class (Corticosteroids, Immunosuppressant, Monoclonal antibodies, Antibiotics, Antivirals, Antifungal, Analgesics) and Disease Type (Anterior Uveitis, Posterior Uveitis, Intermediate Uveitis, Panuveitis) Cause (Infectious Uveitis, Non-Infectious Uveitis), Distribution channel (Hospital Pharmacies, Retail Pharmacies, Others)- Geography.     

Purchase Option

$ 4400
$ 6600
$ 8900

Uveitis Treatment Market size was valued at 581 million in 2022 and is poised to grow at a significant CAGR of 5.7% from 2023 to 2029. Market players are developing novel molecules that can treat uveitis conditions in order to enhance their sales revenue. Companies are focusing on the development of the various drugs in the treatment of the uveitis. For instance, Aurinia Pharmaceuticals Inc. developing Luvenia, a calcineurin inhibitor for the treatment of noninfectious uveitis. Recently it has completed its phase-II clinical trials. Similarly, other pipeline drugs such as EMEA, DE-109, Gevokizumab, Peptide B27PD are being developed by different companies. Considering the aforementioned factors global uveitis treatment market is expected to grow at the significant rate during the forecast period. Uveitis is the term that describes a group of inflammatory diseases that affect the eye and produces swelling. Uveitis can reduce sight and may cause vision loss. Causes of uveitis include infections such as brucellosis, leptospirosis, syphilis, tuberculosis, autoimmune diseases such as sarcoidosis, Crohn's disease, multiple sclerosis, arthritis, ankylosing spondylitis, and psoriatic arthritis. In addition, uveitis is also caused by drugs such as rifabutin and moxifloxacin. Uveitis affects uvea, lens, retina, optic nerve, and vitreous. Uveitis can be classified into anterior uveitis, intermediate uveitis, posterior uveitis and pan-uveitis based on part of inflammation.

Uveitis Treatment Market Dynamics

The main driver for the growth of uveitis market is the rise in prevalence and complications related to uveitis. In addition, increase in prevalence rates, market players betting heavily on research and development to develop new drugs, an introduction of biologics into the market, fast approval of the drugs are fueling the market growth of uveitis treatment market. According to the Ocular Immunology and Uveitis Foundation, worldwide 2,359,242 people are estimated to have the disorder. Even there are significant advances in research and therapeutics, a prevalence of blindness secondary to uveitis has not been reduced in the past thirty years. However, few factors are restraining the growth of the market such as side effects of the drugs, eye irritation and lack of awareness about eye disorders in undeveloped regions, lack of sufficient healthcare infrastructure is hindering the uveitis treatment system market.

Global Uveitis Treatment Market Segmentation

By Drug Class
  • Corticosteroids
  • Immunosuppressant
  • Monoclonal antibodies
  • Antibiotics
  • Antivirals
  • Antifungal
  • Analgesics
By Disease Type
  • Anterior Uveitis
  • Posterior Uveitis
  • Intermediate Uveitis
  • Panuveitis
By Cause
  • Infectious Uveitis
  • Non-Infectious Uveitis
Distribution channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Others

Frequently Asked Questions

The Uveitis Treatment Market was expected to grow at a significant compound annual growth rate (CAGR) of 5.7% from 2023 to 2029. Additionally, it mentions that the market value was USD 581 million in 2022.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

 

  • AbbVie, Inc.
  • Alcon, a Novartis Company
  • Allergan PLC
  • Bausch & Lomb, Inc.
  • Enzo Biochem, Inc.
  • Hanbell Precise Machinery Co. Ltd.
  • Psivida Corporation
  • Regeneron Pharmaceuticals, Inc.
  • Santen Pharmaceutical Co., Ltd.
  • TopiVert Ltd.
  • XOMA Corporation
  • Novartis AG
  • Eyegate Pharmaceuticals, Inc.
1. Executive summary
2. Global Uveitis Treatment Market Introduction
2.1. Global Uveitis Treatment Market - Taxonomy
2.2. Global Uveitis Treatment Market -Definitions
2.2.1. Drug Class Type
2.2.2. Disease Type
2.2.3. Cause
2.2.4. Distribution Channel
3. Global Uveitis Treatment Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Uveitis Treatment Market Dynamics - Factors Impact Analysis
3.6. Global Uveitis Treatment Market - Regulations
3.6.1. U.S
3.6.2. Europe
3.6.3. Japan
3.6.4. China
3.7. Global Uveitis Treatment Market - Product Innovations
4. Global Uveitis Treatment Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis
5. Global Uveitis Treatment Market, By Drug Class, 2018 - 2022 and Forecast, 2023 - 2029
5.1. Corticosteroids
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
5.1.3. Market Opportunity Analysis
5.2. Immunosuppressant
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
5.2.3. Market Opportunity Analysis
5.3. Monoclonal antibodies
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
5.3.3. Market Opportunity Analysis
5.4. Antibiotics
5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
5.4.3. Market Opportunity Analysis
5.5. Antivirals
5.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
5.5.3. Market Opportunity Analysis
5.6. Antifungal
5.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
5.6.3. Market Opportunity Analysis
5.7. Analgesics
5.7.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
5.7.3. Market Opportunity Analysis
6. Global Uveitis Treatment Market Forecast, By Disease Type, 2018 - 2022and Forecast, 2023 - 2029
6.1. Anterior Uveitis
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
6.1.3. Market Opportunity Analysis
6.2. Posterior Uveitis
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
6.2.3. Market Opportunity Analysis
6.3. Intermediate Uveitis
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
6.3.3. Market Opportunity Analysis
6.4. Panuveitis
6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
6.4.3. Market Opportunity Analysis
7. Global Uveitis Treatment Market Forecast, By Cause, 2018 - 2022and Forecast, 2023 - 2029
7.1. Infectious Uveitis
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
7.1.3. Market Opportunity Analysis
7.2. Non-Infectious Uveitis
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
7.2.3. Market Opportunity Analysis
8. Global Uveitis Treatment Market Forecast, By Distribution Channel, 2018 - 2022and Forecast, 2023 - 2029
8.1. Hospital Pharmacies
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
8.1.3. Market Opportunity Analysis
8.2. Retail Pharmacies
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
8.2.3. Market Opportunity Analysis
8.3. Others
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
8.3.3. Market Opportunity Analysis
9. Global Uveitis Treatment Market Forecast, By Region, 2018 - 2022and Forecast, 2023 - 2029
9.1. North America
9.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
9.5.3. Market Opportunity Analysis
9.6. Global Uveitis Treatment Market - Opportunity Analysis Index, By Drug Class Type, By Disease Type, Cause,  Distribution Channel, and Region, 2023 - 2029
10. North America Uveitis Treatment Market Analysis, 2018 - 2022and Forecast, 2023 - 2029
10.1.1. Drug Class Analysis (2018 - 2022) and Forecast ( 2023 - 2029 ) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1.1. Corticosteroids
10.1.1.2. Immunosuppressant
10.1.1.3. Monoclonal antibodies
10.1.1.4. Antibiotics
10.1.1.5. Antivirals
10.1.1.6. Antifungal
10.1.1.7. Analgesics
10.1.2. Disease Type Analysis (2018 - 2022) and Forecast ( 2023 - 2029 ) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.2.1. Anterior Uveitis
10.1.2.2. Posterior Uveitis
10.1.2.3. Intermediate Uveitis
10.1.2.4. Panuveitis
10.1.3. Cause Analysis (2018 - 2022) and Forecast ( 2023 - 2029 ) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.3.1. Infectious Uveitis
10.1.3.2. Non Infectious Uveitis
10.1.4. Distribution Channel Analysis (2018 - 2022) and Forecast ( 2023 - 2029 ) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.4.1. Hospital Pharmacies
10.1.4.2. Retail Pharmacies
10.1.4.3. Others
10.1.5. Country Analysis (2018 - 2022) and Forecast ( 2023 - 2029 ) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.1.5.1. U.S.
10.1.5.2. Canada
10.1.6. North America Uveitis Treatment Market - Opportunity Analysis Index, By Drug Class, Disease Type, Cause, Distribution Channel and Country, 2023 - 2029
10.1.7. North America Uveitis Treatment Market Dynamics - Trends
11. Europe Uveitis Treatment Market Analysis, 2018 - 2022and Forecast, 2023 - 2029
11.1.1. Drug Class Analysis (2018 - 2022) and Forecast ( 2023 - 2029 ) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1.1. Corticosteroids
11.1.1.2. Immunosuppressant
11.1.1.3. Monoclonal antibodies
11.1.1.4. Antibiotics
11.1.1.5. Antivirals
11.1.1.6. Antifungal
11.1.1.7. Analgesics
11.1.2. Disease Type Analysis (2018 - 2022) and Forecast ( 2023 - 2029 ) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.2.1. Anterior Uveitis
11.1.2.2. Posterior Uveitis
11.1.2.3. Intermediate Uveitis
11.1.2.4. Panuveitis
11.1.3. Cause Analysis (2018 - 2022) and Forecast ( 2023 - 2029 ) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.3.1. Infectious Uveitis
11.1.3.2. Non Infectious Uveitis
11.1.4. Distribution Channel Analysis (2018 - 2022) and Forecast ( 2023 - 2029 ) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.4.1. Hospital Pharmacies
11.1.4.2. Retail Pharmacies
11.1.4.3. Others
11.1.5. Country Analysis (2018 - 2022) and Forecast ( 2023 - 2029 ) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.5.1. Germany
11.1.5.2. UK
11.1.5.3. France
11.1.5.4. Spain
11.1.5.5. Italy
11.1.5.6. Russia
11.1.5.7. Poland
11.1.5.8. Rest of Europe
11.1.6. Europe Uveitis Treatment Market - Opportunity Analysis Index, By Drug Class, Disease Type, Cause, Distribution Channel and Country, 2023 - 2029
11.1.7. Europe Uveitis Treatment Market Dynamics - Trends
12. Asia-Pacific Uveitis Treatment Market Analysis, 2018 - 2022and Forecast, 2023 - 2029
12.1.1. Drug Class Analysis (2018 - 2022) and Forecast ( 2023 - 2029 ) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1.1. Corticosteroids
12.1.1.2. Immunosuppressant
12.1.1.3. Monoclonal antibodies
12.1.1.4. Antibiotics
12.1.1.5. Antivirals
12.1.1.6. Antifungal
12.1.1.7. Analgesics
12.1.2. Disease Type Analysis (2018 - 2022) and Forecast ( 2023 - 2029 ) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.2.1. Anterior Uveitis
12.1.2.2. Posterior Uveitis
12.1.2.3. Intermediate Uveitis
12.1.2.4. Panuveitis
12.1.3. Cause Analysis (2018 - 2022) and Forecast ( 2023 - 2029 ) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.3.1. Infectious Uveitis
12.1.3.2. Non Infectious Uveitis
12.1.4. Distribution Channel Analysis (2018 - 2022) and Forecast ( 2023 - 2029 ) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.4.1. Hospital Pharmacies
12.1.4.2. Retail Pharmacies
12.1.4.3. Others
12.1.5. Country Analysis (2018 - 2022) and Forecast ( 2023 - 2029 ) by Revenue (USD Mn),
Y-o-Y Growth (%), and Market Share (%)
12.1.5.1. Japan
12.1.5.2. China
12.1.5.3. India
12.1.5.4. ASEAN
12.1.5.5. Australia & New Zealand
12.1.5.6. Rest of Asia-Pacific
12.1.6. Asia-Pacific Uveitis Treatment Market - Opportunity Analysis Index, By Drug Class, Disease Type, Cause, Distribution Channel and Country, 2023 - 2029
12.1.7. Europe Uveitis Treatment Market Dynamics - Trends
13. Latin America Uveitis Treatment Market Analysis, 2018 - 2022and Forecast, 2023 - 2029
13.1.1. Drug Class Analysis (2018 - 2022) and Forecast ( 2023 - 2029 ) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1.1. Corticosteroids
13.1.1.2. Immunosuppressant
13.1.1.3. Monoclonal antibodies
13.1.1.4. Antibiotics
13.1.1.5. Antivirals
13.1.1.6. Antifungal
13.1.1.7. Analgesics
13.1.2. Disease Type Analysis (2018 - 2022) and Forecast ( 2023 - 2029 ) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.2.1. Anterior Uveitis
13.1.2.2. Posterior Uveitis
13.1.2.3. Intermediate Uveitis
13.1.2.4. Panuveitis
13.1.3. Cause Analysis (2018 - 2022) and Forecast ( 2023 - 2029 ) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.3.1. Infectious Uveitis
13.1.3.2. Non Infectious Uveitis
13.1.4. Distribution Channel Analysis (2018 - 2022) and Forecast ( 2023 - 2029 ) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.4.1. Hospital Pharmacies